Abacus Planning Group, Inc. Amgen Inc Transaction History

Abacus Planning Group, Inc.

$545 Million
Q3 2024

A detailed history of Abacus Planning Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 3,676 shares of AMGN stock, worth $967,449. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,676

Previous 4,394 16.34%

Holding current value

$967,449

Previous $1.37 Million 13.7%

% of portfolio

0.22%

Previous 0.27%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$309.38 - $337.38 $222,134 - $242,238	-718 Reduced 16.34%	3,676 $1.18 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $8,933 - $10,856	34 Added 0.78%	4,394 $1.37 Million
Q4 2023 Jan 19, 2024	SELL	$255.7 - $288.46 $6,903 - $7,788	-27 Reduced 0.62%	4,360 $1.26 Million
Q3 2023 Oct 11, 2023	SELL	$218.65 - $271.46 $1,530 - $1,900	-7 Reduced 0.16%	4,387 $1.18 Million
Q2 2023 Jul 06, 2023	BUY	$214.27 - $253.37 $21,427 - $25,337	100 Added 2.33%	4,394 $975,000
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $6,412 - $8,148	-28 Reduced 0.65%	4,294 $0
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $49,381 - $55,693	220 Added 5.36%	4,322 $974,000
Q1 2022 Apr 13, 2022	SELL	$219.27 - $242.57 $1,534 - $1,697	-7 Reduced 0.17%	4,102 $992,000
Q3 2021 Oct 19, 2021	SELL	$212.27 - $248.7 $30,566 - $35,812	-144 Reduced 3.39%	4,109 $874,000
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $33,869 - $37,575	145 Added 3.53%	4,253 $1.04 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $37,217 - $44,319	172 Added 4.37%	4,108 $945,000
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $1,093 - $1,450	6 Added 0.15%	3,936 $798,000
Q4 2019 Jan 30, 2020	SELL	$189.21 - $243.2 $3,973 - $5,107	-21 Reduced 0.53%	3,930 $947,000
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $2,089 - $2,503	12 Added 0.3%	3,951 $765,000
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $9,335 - $10,942	-56 Reduced 1.4%	3,939 $726,000
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $4,340 - $4,893	-24 Reduced 0.6%	3,995 $759,000
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $447,427 - $522,291	2,508 Added 165.98%	4,019 $782,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $447,427 - $522,291	-2,508 Reduced 62.4%	1,511 $220,000
Q4 2018 Jan 25, 2019	BUY	$178.4 - $208.25 $5,352 - $6,247	30 Added 0.75%	4,019 $782,000
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $34,649 - $39,062	-187 Reduced 4.48%	3,989 $826,000
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $2,490 - $2,797	15 Added 0.36%	4,176 $770,000
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $17,790 - $20,790	-105 Reduced 2.46%	4,161 $709,000
Q4 2017 Mar 06, 2018	BUY	$168.79 - $188.59 $720,058 - $804,524	4,266	4,266 $742,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Account

Abacus Planning Group, Inc. Amgen Inc Transaction History